Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII for Preventing Early Hematoma Growth in Acute Intracerebral Haemorrhage

Inclusion Criteria: * Spontaneous ICH diagnosed by CT (Computerized Tomography) scanning within 3 hours of onset * Signed informed consent form, or an exception from standard informed consent requirements Exclusion Criteria: * Time of onset of symptoms of ICH unknown or more than 3 hours prior to CT * Patients with secondary ICH related to infarction, hemophilia or other coagulopathy, tumor, trauma, haemorrhagic infarction, cerebrovenous thrombosis, aneurysm, AVM (Arteriovenous Malformation) or severe trauma * Surgical haematoma evacuation planned or performed within 24 hours of onset